Dr. Christian G. Nageotte, MD

Dr. Nageotte practices at Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health.

Dr. Nageotte's NPI, 1780785204, was assigned on September 26, 2006. Dr. Nageotte graduated from American University of the Caribbean School of Medicine in 1998. Dr. Nageotte holds Michigan license 4301072658.

Dr. Nageotte's primary practice is Henry Ford Hospital, at 2799 W Grand Blvd, Detroit, MI 48202 in Wayne County. The practice phone is (313) 916-2600.

Dr. Nageotte's primary practice is Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health. Dr. Nageotte is also affiliated with Henry Ford West Bloomfield Hospital. The medical group on file is Henry Ford Health. Dmand AI also links Dr. Nageotte to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nageotte practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy is Dr. Nageotte's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. Nageotte is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Nageotte's licenses on file in 2 states: Michigan and Florida.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, hives, immune deficiency disease and upper respiratory infection (URI) among the conditions Dr. Nageotte treats.

CMS data shows 394 Medicare services from Dr. Nageotte across 6 procedure codes in 2024, for 202 Medicare patients. Medicare paid $20,571 for them. Every service was in an office.

CMS counts 202 Medicare patients who saw Dr. Nageotte in 2024. The largest group is 65 to 74, with 102 patients. 67% of them have high cholesterol, and 64% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nageotte's median patient age at 47, with 62% women.

In 2024, Dr. Nageotte wrote 1,947 Medicare Part D claims for 301 patients. 59% of them were for generic drugs. CMS names the drug for 1,742 of them, across 40 drugs with 11 or more claims each, at $2,632,131 in total drug cost. In 2023, CMS named 1,642 claims across 37 drugs.

Dr. Nageotte accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nageotte as offering telehealth.

Dmand AI links 11 papers to Dr. Nageotte, published from 2006 to 2016. 2014 was the busiest year, with 2. The most frequent topics are Immunoglobulin E, Allergens and Food Hypersensitivity. Dr. Nageotte has published most often in Ann Allergy Asthma Immunol. Dr. Nageotte's most frequent co-authors are Dennis R. Ownby, MD, Edward M. Zoratti, MD and Rana Tawil Misiak, MD.

CMS Open Payments shows 114 general payments to Dr. Nageotte from 8 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 75% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $29,311.

Dmand AI lists 4 awards for Dr. Nageotte, most recently Regional Top Doctor in 2014.

Dr. Nageotte graduated from American University of the Caribbean School of Medicine in 1998. Dr. Nageotte is a member of AAAAI.

Dr. Nageotte is in network with 13 carriers, including Aetna, Health Alliance Plan and Priority Health. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.